Overview
- Tilray shares rose roughly 40% for the week through Thursday, according to S&P Global Market Intelligence data.
- A pro-CBD video posted by President Trump on Truth Social, produced by The Commonwealth Project, was cited as the main catalyst and lifted cannabis stocks broadly.
- Tilray announced an expansion of its medical portfolio in Germany, including five new cannabis flower products for physicians and pharmacies.
- CBD remains legal under the 2018 Farm Bill, yet the FDA excludes it from food supplements and Medicare does not cover over-the-counter CBD.
- Coverage highlights the sector’s history of short-lived rallies tied to policy hopes, even as Tilray spans recreational cannabis in Canada, medical cannabis in Europe, CBD drinks, and alcohol.